Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Gajarski

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Current Cardiology Reviews|May 2, 2012
Postoperative care of the transplanted patientKurt R Schumacher, Robert J Gajarski
Pediatric Transplantation|January 2, 2023
Two sides of the same coin: Balancing the risks of rejection and infection in transplanted Fontan patients with dysregulated pretransplant immune functionLydia K Wright, Robert J Gajarski
Congenital Heart Disease|December 20, 2011
Pediatric coronary allograft vasculopathy--a review of pathogenesis and risk factorsKurt R Schumacher, Robert J Gajarski, Simon Urschel
Pediatric Cardiology|April 12, 2011
Safety profile of decellularized, cryopreserved pulmonary allografts when used in the aortic position for neonatal arch reconstructionMarc D Knepp, Richard G Ohye, Robert J Gajarski
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 23, 2023
Racial and socioeconomic disparities in status exceptions for pediatric heart transplant candidates under the current U.S. Pediatric Heart Allocation PolicyLydia K Wright, Stacey Culp, Robert J Gajarski, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 11, 2024
Equity and center variation in listing status exceptions for pediatric heart transplant candidates since pediatric review board implementationLydia K Wright, Stacey Culp, Robert J Gajarski, et al.
Pediatric Transplantation|April 4, 2017
Dopamine as a potential rescue therapy for refractory protein-losing enteropathy in Fontan-palliated patientsJoshua M Friedland-Little, Robert J Gajarski, Kurt R Schumacher
Pediatric Transplantation|November 9, 2012
An apparent case of undiagnosed donor Kawasaki disease manifesting as coronary artery aneurysm in a pediatric heart transplant recipientJoshua Friedland-Little, Ranjit Aiyagari, Robert J Gajarski, et al.
Echocardiography (Mount Kisco, N.Y.)|July 1, 1996
Echocardiographic Evaluation of Common Atrioventricular Canal Defects: A Study of 206 Consecutive PatientsTal Geva, Nancy A. Ayres, Ricardo H. Pignatelli, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 17, 2004
Lack of correlation between MMF dose and MPA level in pediatric and young adult cardiac transplant patients: does the MPA level matter?Robert J Gajarski, Dennis C Crowley, Mary C Zamberlan, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Current Cardiology Reviews|May 2, 2012
Postoperative care of the transplanted patientKurt R Schumacher, Robert J Gajarski
Pediatric Transplantation|January 2, 2023
Two sides of the same coin: Balancing the risks of rejection and infection in transplanted Fontan patients with dysregulated pretransplant immune functionLydia K Wright, Robert J Gajarski
Congenital Heart Disease|December 20, 2011
Pediatric coronary allograft vasculopathy--a review of pathogenesis and risk factorsKurt R Schumacher, Robert J Gajarski, Simon Urschel
Pediatric Cardiology|April 12, 2011
Safety profile of decellularized, cryopreserved pulmonary allografts when used in the aortic position for neonatal arch reconstructionMarc D Knepp, Richard G Ohye, Robert J Gajarski
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 23, 2023
Racial and socioeconomic disparities in status exceptions for pediatric heart transplant candidates under the current U.S. Pediatric Heart Allocation PolicyLydia K Wright, Stacey Culp, Robert J Gajarski, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 11, 2024
Equity and center variation in listing status exceptions for pediatric heart transplant candidates since pediatric review board implementationLydia K Wright, Stacey Culp, Robert J Gajarski, et al.
Pediatric Transplantation|April 4, 2017
Dopamine as a potential rescue therapy for refractory protein-losing enteropathy in Fontan-palliated patientsJoshua M Friedland-Little, Robert J Gajarski, Kurt R Schumacher
Pediatric Transplantation|November 9, 2012
An apparent case of undiagnosed donor Kawasaki disease manifesting as coronary artery aneurysm in a pediatric heart transplant recipientJoshua Friedland-Little, Ranjit Aiyagari, Robert J Gajarski, et al.
Echocardiography (Mount Kisco, N.Y.)|July 1, 1996
Echocardiographic Evaluation of Common Atrioventricular Canal Defects: A Study of 206 Consecutive PatientsTal Geva, Nancy A. Ayres, Ricardo H. Pignatelli, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 17, 2004
Lack of correlation between MMF dose and MPA level in pediatric and young adult cardiac transplant patients: does the MPA level matter?Robert J Gajarski, Dennis C Crowley, Mary C Zamberlan, et al.
Pageof 7